INA Board Members

Anthony David

I graduated in medicine from Glasgow University, Scotland and did some neurology training there before joining the Maudsley Hospital to do psychiatry training. There I worked with Alwyn Lishman and others who inspired me to become a neuropsychiatrist. My research has used neuropsychology and neuroimaging to help understand psychiatric disorders, especially schizophrenia but also FND and depersonalisation disorder. An overriding interest of mine is insight in neuropsychiatry. I was Vice Dean at the Institute of Psychiatry, King’s College London until 2018 when I moved to University College London to become director of the UCL Institute of Mental Health.

Valsa Eapen

Valsa Eapen is Professor and Chair of Infant, Child and Adolescent Psychiatry, UNSW Sydney & Head, Academic Unit of Child Psychiatry South West Sydney (AUCS). Eapen serves as Treasurer and President Elect of International Neuropsychiatry Association; Chair of Faculty of Child and Adolescent Psychiatry, Royal Australian and New Zealand College of Psychiatry (RANZCP); World Psychiatric Association (WPA) Co-Chair for Psychiatry in Developing countries and Oceania Zonal representative. Eapen has published over 400 journal articles, 6 books, 50 book chapters and is currently part of research programs totalling over 40 Million dollars in funding including leading a NHMRC Centre of Research Excellence.

Julian Trollor

Julian is a neuropsychiatrist and holds the inaugural Chair of Intellectual Disability Mental Health, University of New South Wales (UNSW Sydney). He heads the Department of Developmental Disability Neuropsychiatry (3DN), Discipline Psychiatry, is a NHMRC Leadership Fellow, and acting Director for the Centre of Excellence in Intellectual Disability Health, UNSW Sydney.

Julian and 3DN work to improve health policy, practice and supports for people with an intellectual or developmental disability through teaching, training, health promotion, and educational resources. 3DN conducts research with benefit to disability and health sectors, provides consultancy, clinical consultations, advocacy and contributions to policy and legislative reviews.

Elvina Chu

Dr Elvina Chu is a Neuropsychiatrist at Kingston Health Sciences Centre and Associate Professor in the Dept of Psychiatry at Queen’s University in Ontario, Canada where her research group is investigating eye movements and the neuropsychiatry of rehabilitation. She established a new Huntington Disease clinic in Kingston in 2022. A graduate from Guy’s and St Thomas’ Medical Schools in London, England, she completed the prestigious Maudsley training scheme and developed the first in-patient Huntington’s disease service in the UK. She was elected to Fellowship of the Royal College of Psychiatrists (UK) in 2021.

e.chu@queensu.ca

Richard Kanaan

Professor Richard Kanaan studied mathematics and philosophy in Oxford and Los Angeles, before training in medicine and psychiatry in London. He was a clinician and academic at the Maudsley Hospital/Institute of Psychiatry in London until he was appointed Chair of Psychiatry at Austin Hospital, and Professor of Psychiatry at the University of Melbourne in 2013. His special interests include functional syndromes, schizophrenia and the philosophy of psychiatry. He started the first functional neurology clinic at King’s College Hospital in London, and the first functional neurology clinic at Austin Health in Melbourne.

Perminder Sachdev

Perminder Sachdev AM MBBS MD FRANZCP PhD FAHMS is Scientia Professor of Neuropsychiatry, Co-Director of the Centre for Healthy Brain Ageing (CHeBA) in the School of Psychiatry, UNSW Sydney, and Clinical Director of the Neuropsychiatric Institute (NPI) at the Prince of Wales Hospital, Sydney, Australia. He is co-chair of the Australian Dementia Network (ADNeT) and Director of the Centre of Research Excellence in Vascular Contributions to Dementia. His major areas of research are drug-induced movement disorders, brain imaging, cognitive ageing and dementia. He has published over 800 peer-reviewed journal papers and 6 books, including one for lay readers (The Yipping Tiger and other tales from the neuropsychiatric clinic) and a book of poems (A migrant’s musings). He was named NSW Scientist of the year for Biomedical Sciences in 2010. In 2011, he was appointed Member of the Order of Australia (AM) for services to medical research. In 2018, he won the DARF-Yulgilbar Innovation Award for dementia research. In 2022, he was awarded the Ryman Prize by an international jury for the most significant contributions world-wide toward the health of older people.

Eileen Joyce

Eileen Joyce is Emeritus Professor of Neuropsychiatry at Queen Square UCL Institute of Neurology and an honorary consultant neuropsychiatrist at The National Hospital for Neurology and Neuropsychiatry. Her research has focused on interventions for neuropsychiatric disorders such as schizophrenia, OCD and Tourette’s syndrome and their mechanisms of action. Her clinic work has involved the management of complex neuropsychiatric disorders. She obtained her first degree in experimental psychology and PhD in dopamine psychopharmacology from the University of Cambridge. She went on to study medicine also at Cambridge. She trained in psychiatry at the Bethlem and Maudsley Hospitals. She has served as Chair of the British Neuropsychiatry Association, the RCPsych Faculty of Neuropsychiatry and the International Neuropsychiatric Association. She is currently a trustee of the charity Tourette’s A.

Colin Shapiro

Colin Shapiro trained in medicine in South Africa and published in Science and Experiencia as an undergraduate student. He went to Edinburgh to do a PhD in Sleep, and then trained in psychiatry. At a young age and he was appointed as a Full Professor in Psychiatry at the University of Toronto.

He has published over 300 papers, five academic books and 15 booklets for patients – largely in the sleep field.

He was the editor of the journal ‘ Psychosomatic Research’ for 18 years and currently is the editor of the Sleep section of the journal Frontiers of Sleep.

He was the co-founder of the British Sleep Society and the founder of INA – The International Neuropsychiatry Association and designed its logo.

Jasvinder Singh

Dr Jasvinder Singh is a consultant neuropsychiatrist with a keen interest in research and teaching.

Dr Singh has extensive experience of working as a consultant neuropsychiatrist in a regional tertiary centre in UK. He has vast experience in the assessment and management of neurological conditions with a neuropsychiatric profile including epilepsy, stroke, multiple sclerosis, functional neurological disorders, traumatic and other acquired brain injuries, movement disorders including Huntington’s, Parkinson’s disease and Tourette’s, sleep disorders and dementias.

Dr Singh did his undergraduate medical training from India in 2001. He did his postgraduate training in psychiatry from Yorkshire and Humber Deanery, UK in 2008. He completed his master’s in clinical Psychiatry (MMedSc) from Leeds University, UK and later gained Membership of the Royal College of Psychiatrists (MRCPsych), UK in 2008. He completed his specialist training in psychiatry from UK in old age and was accredited with CCT in old age in 2012. He completed his fellowship in psychiatry from the Royal Australian and New Zealand college of Psychiatrists (FRANZCP) in 2019. He is currently working both in Public and private sector.

Dr Singh is a Senior Lecturer at the University of Queensland, Brisbane, Australia. He has been involved in research and is a published author in research journals. When not working he enjoys spending time with his family, travelling, playing racquet sports, listening to music and reading nonfiction books on culture, history, spirituality, philosophy, mind and brain.

Dr Singh is also the founder of Global Neuropsychiatry Group.

He can be contacted at globalneuropsychiatryg@gmail.com.

Florence Thibaut

Florence Thibaut, M.D., Ph.D., is Professor of Psychiatry at the University Hospital Cochin Paris and the University of Paris Cité, France.

Psychiatrist and Endocrinologist, PhD in Neurosciences.

Her main interests are in psychopharmacology, addictive disorders, genetics of schizophrenia, sexual violence and in women’s mental health. She is Member of INSERM U1266, Institute for Psychiatry and Neurosciences.

She was President of the French Association for Biological Psychiatry (2007-2009).

She is Honorary President of the World Federation of Societies of Biological Psychiatry (2013-).

She is Immediate Past President of the International Association for Women’s Mental Health (President 2019-2022).

She is Chair of the Women’s Mental Health Section of the World Psychiatric Association (2023-).

She is an EC Member of the International Neuropsychiatric Association (2013-).

She is Editor-in-Chief of Dialogues in Clinical Neurosciences (2014-) (IF 6.3). She is a Member of the Editorial Board of the European Archives Psychiatry and Clinical Neurosciences and the Archives of Women’s Mental Health.

She is a Member of several national and European jury boards for grants allocations.

She is author or coauthor of more than 300 papers (190 in PubMed), 7 books (genetics of schizophrenia and psychiatric aspects of deviant sexual disorders, neurosciences in psychiatry, sexual abuse, antipsychotics and 2 coeditions) and 75 books chapters including 19 in English (Factor H: 42-51, Web of Sci.; Google Sch.).

She was an invited speaker in many national and international meetings (532 communications including more than 66 plenary lectures).

She has coordinated several national and international congresses (WFSBP; IAWMH). She is involved in the scientific advisory board of the European College of Neuropsychopharmacology.

She was a member of the French drug agency, of the national board for neuroscience research (INSERM). She was Vice- President of the national board of Professors in addiction.

She has coordinated several research grants (including national research programs in France).

She is the current Chair of the Scientific Committee of the French Association of Families of Mentally-Ill people (UNAFAM) (member of GAMIAN).

She was an elected member of the Senat of the Paris University and of the Executive Board of its Faculty of Health (2019- 2023).

Recent awards:

Knight of the Legion of Honour (given by the Minister of Gender equality) July 2019 Excellence in Education WFSBP award 2017

Mathew Varghese

Dr Mathew Varghese is a Senior Professor of Psychiatry currently at St John’s Medical College, Bangalore, India at the Geriatric Psychiatry Services. Formerly, he was a faculty member at the Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore for over 35 years. He worked in General Adult Psychiatry and Geriatric Psychiatry and was responsible for developing the Geriatric Psychiatry Services and Specialised training programs. He held different positions as the Head of the Department of Psychiatry and the Head of the Geriatric Psychiatry Services at NIMHANS, Bangalore. His main areas of research are in Geriatric Psychiatry, Family Interventions and Psychiatric Epidemiology.

mat.varg@yahoo.com

Ludger Tebartz van Els

I studied medicine and philosophy at the Universities of Freiburg/Germany, Manchester/UK, NYU Medical Center, NY/USA and Zürich/Switzerland. I then started my training in neurology in Freiburg, did a clinical post-doc in neuropsychiatry at the Neuropsychiatry Department of the Institute of Neurology/Queen Square London (with Prof. Michael Trimble) and returned to Freiburg to do my psychiatry training. I am Professor for Psychiatry and Psychotherapy and head of the section for experimental neuropsychiatry and deputy director of the clinic for psychiatry and psychotherapy in Freiburg. My focus of medical clinical and basic research is autism and other neurodevelopmental disorders and for about 20 years now the neuropsychiatry mainly of psychotic but also all other primary psychiatric disorders. My strong belief is that the future not only for neuropsychiatry but also for psychiatry in general lies in more case-based research. This should progress from individual deep phenotyping together with a thorough clinical assessment including EEG, MRI, CSF, PET and lab studies in severe debilitating psychiatric disorder to cumulative case descriptions and eventually to an approach of reverse phenotyping defining nosologic categories on these new grounds.

tebartzvanelst@uniklinik-freiburg.de